Combination of azacitidine and enasidenib enhances leukemic cell differentiation and cooperatively hypomethylates DNA. MacBeth KJ, Chopra VS, Tang L, Zheng B, et al. Exp Hematol 2021;98:47-52.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

MacBeth KJ, Chopra VS, Tang L, Zheng B, et al. Combination of azacitidine and enasidenib enhances leukemic cell differentiation and cooperatively hypomethylates DNA. Exp Hematol 2021;98:47-52.
PMID: 33794295